Friday, 16 Feb 2018

You are here

New Rise in Hip Fractures Amongst Women

Reuters reports that the incidence of hip fractures in older women in the U.S. is rising after more than a decade of decline, according to a large new study of Medicare recipients.

Researchers analyzed Medicare claims data from 2002 to 2015, from more than 2 million women age 65 or older. They found that hip fracture rates declined each year from 2002 to 2012, the researchers found. But starting in 2013, hip fracture rates leveled off and were higher than expected. 

Increases in fracture rates were prominent in women ages 65 to 69, which had risen by 2.5 percent, and in women ages 70 to 74, which had risen by 3.8 percent, from 2014 through 2015.

The net results is more than 11,000 additional estimated hip fractures over the time periods 2013 to 2015. 

The U.S. Preventive Services Task Force (USPSTF) recommends that women age 65 or older get screened for osteoporosis with a type of X-ray called a DXA scan to measure bone loss. Postmenopausal women under age 65, with risk factors for osteoporosis, should also be screened. Risk factors include a family history of osteoporosis, diseases such as rheumatoid arthritis, the use of certain medications, and smoking and drinking alcohol.

One possible explanation, they say, is that use of DXA testing has steadily declined. Because DXA is used to diagnose osteoporosis before the first fracture occurs and to monitor the skeletal effects of treatment, a decline in its use could be related to a rise in hip fracture rates, they suggest.

Another factor causing hip fracture rates to rise, they say, could be a decrease in osteoporosis treatment – partly because fewer women are being screened and diagnosed, and partly because patients may fear the rare but severe side effects that have been linked with osteoporosis drugs called bisphosphonates.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Teriparatide Superior to Risedronate in the VERO Trial

Lancet reports that in a study teriparatide with risedronate, post-menopausal women with severe osteoporosis had significantly fewer new vertebral and clinical fractures on teriparatide comared to those receiving risedronate.

This trial is one of the first to compare osteoporosis drugs with incident fractures as the primary outcome.

Two Types of Osteoarthritis Based on Cartilage Studies

A report from Annals of Rheumatic Diseases suggests that osteoarthritis (OA) may be two distinct diseases based on genetic studies of articular cartilage. (Citation source: https://buff.ly/2mNtUsL).

RNA sequencing of knee cartilage from 44 OA patients undergoing total knee replacement was compared to 6 additional patients with OA and 10 control patients with non-OA.

Calcium and Vitamin D Supplements Do Not Reduce Hip Fractures

Recent JAMA study shows metanalysis of 33 clinical trials and 51,145 participants, showed that calcium, vitamin D, or both affords no decreased risk of hip fractures compared with placebo or no treatment and therefore questions their routine widespread use in the elderly.. 

Community Screening for Fracture Risk in Older Women is Effective and Feasible

A UK Study published in Lancet shows that community-based screening programme for fracture risk in older women is feasible, and may reduce hip fractures. 

Older women, age 70-85 yrs, were identified and participated in the trial and were assessed using the Fracture Risk Assessment Tool (FRAX) with usual management. 12 483 were enrolled and 6233 women randomly assigned to the screening group.

Knee Surgery Outcomes Worse with Low Education

Reuters reports that patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, citing results from a recent study from the Hospital for Special Surgery in NY.